EUROPE IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026
Europe Immunohistochemistry Market by Products (Antibodies, Equipment, Reagents, Kits) by Applications (Diagnostics, Testing) by End Users (Hospitals and Diagnostic Laboratories, Research Institutes, Other End-users) & by Geography.
Europe has witnessed enhanced funding for academic research in the year 2017 which is boosting more science projects in the region. The highest funding is seen in countries like Germany, United Kingdom, and France. Moreover, developing technologies is pushing the immunohistochemistry market to exhibit at 7.88% of CAGR during the years 2018-2026.
The United Kingdom leads the immunohistochemistry market in Europe region. The propelling incidences of cardiovascular diseases mainly in semi-urban and urban counties is escalating the demand and development of the immunohistochemistry market in the country. The other countries present in the region are France, Germany, Spain, Italy, Russia and rest of Europe. The high prevalence of diabetes is acting as the major growth factor for immunohistochemistry market in Germany. However, limitations of closed systems is the key factor hindering the market growth in the region.
The flourished players in the market are Abbott Laboratories, Bio Sb, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Histologix, Abcam Plc, Biogenex, Merck Millipore, Cell Signaling Technology Inc., F. Hoffmann-La Roche Ag, Danaher Corporation, Perkinelmer Inc., and Siemens Ag Healthcare.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- REAGENTS PRODUCTS ARE GROWING AT A SIGNIFICANT RATE
- DIAGNOSTICS IS MAJORLY USED APPLICATION IN THE MARKET
- HOSPITALS AND DIAGNOSTIC LABORATORIES HOLDS THE LARGEST MARKET SHARE IN THE END-USERS MARKET
- MARKET DETERMINANTS
- MARKET DRIVERS
- RISING CANCER INCIDENCE
- TECHNOLOGICAL EXPANSIONS IN IN-VITRO DIAGNOSTIC COMMERCE
- INCREASING HEALTHCARE SPENDING
- GROWING POPULARITY OF POC TESTING
- MARKET RESTRAINTS
- INSURANCE COVERAGE AND REIMBURSEMENT ISSUES
- LIMITATIONS OF CLOSED SYSTEMS
- PRESENCE OF AN UNDIAGNOSED POPULATION
- MARKET OPPORTUNITIES
- USE OF BIOMARKERS FOR DISEASE DIAGNOSIS AND INCREASING EFFICIENCY
- PARADIGM SHIFT TOWARD PRECISION DIAGNOSIS THROUGH PERSONALIZED MEDICINE
- ADVANCEMENTS IN TECHNOLOGIES
- MARKET CHALLENGES
- HIGH INITIAL INVESTMENT AND MAINTENANCE COST
- STRINGENT REGULATION FOR APPROVAL OF DEVICES
- PRICING PRESSURE COUPLED WITH LACK OF PRODUCT DIFFERENTIATION
- MARKET DRIVERS
- MARKET SEGMENTATION
- MARKET BY PRODUCTS 2018-2026
- ANTIBODIES
- PRIMARY ANTIBODIES
- SECONDARY ANTIBODIES
- EQUIPMENT
- SLIDE STAINING SYSTEMS
- TISSUE MICROARRAYS
- TISSUE PROCESSING SYSTEMS
- SLIDE SCANNERS
- OTHER EQUIPMENT’S
- REAGENTS
- HISTOLOGICAL STAINS
- BLOCKING SERA AND REAGENTS
- CHROMOGENIC SUBSTRATES
- FIXATION REAGENTS
- STABILIZERS
- ORGANIC SOLVENTS
- PROTEOLYTIC ENZYMES
- DILUENTS
- KITS
- ANTIBODIES
- MARKET BY APPLICATIONS 2018-2026
- DIAGNOSTICS
- CANCER
- INFECTIOUS DISEASES
- CARDIOVASCULAR DISEASE
- AUTOIMMUNE DISEASES
- DIABETES MELLITUS
- NEPHROLOGICAL DISEASES
- DRUG TESTING
- DIAGNOSTICS
- MARKET BY END-USERS 2018-2026
- HOSPITALS AND DIAGNOSTIC LABORATORIES
- RESEARCH INSTITUTES
- OTHER END USERS
- MARKET BY PRODUCTS 2018-2026
- KEY ANALYTICS
- IMMUNOHISTOCHEMISTRY ETYMOLOGY
- VALUE CHAIN ANALYSIS
- RAW MATERIAL SUPPLIERS
- MANUFACTURERS
- DISTRIBUTORS
- END-USERS
- OPPORTUNITY MATRIX
- GEOGRAPHICAL ANALYSIS
- EUROPE
- THE UNITED KINGDOM
- FRANCE
- GERMANY
- SPAIN
- ITALY
- RUSSIA
- REST OF EUROPE
- EUROPE
- COMPANY PROFILES
- ABBOTT LABORATORIES
- COMPANY PROFILE
- PRODUCT PORTFOLIO
- SWOT ANALYSIS
- STRATEGIC INITIATIVES
- ABCAM PLC
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- AGILENT TECHNOLOGIES, INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- BIOGENEX
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- BIO-RAD LABORATORIES, INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- BIO SB
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- CELL SIGNALING TECHNOLOGY, INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- DANAHER CORPORATION
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- HOFFMANN-LA ROCHE AG
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS:
- STRATEGIC INITIATIVES
- HISTOLOGIX
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- MERCK MILLIPORE
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- PERKINELMER, INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- SIEMENS AG HEALTHCARE
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SWOT ANALYSIS
- STRATEGIC INITIATIVES
- THERMO FISHER SCIENTIFIC INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- ABBOTT LABORATORIES
TABLE LIST
TABLE 1 EUROPE MARKET FOR IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
TABLE 2 CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT
TABLE 3 POPULATION AGED 60 YEARS AND ABOVE
TABLE 4 POPULATION AGED 80 YEARS AND ABOVE
TABLE 5 EUROPE IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2018-2026 ($ MILLION)
TABLE 6 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2018-2026 ($ MILLION)
TABLE 7 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES BY TYPES 2018-2026 ($ MILLION)
TABLE 8 EUROPE ANTIBODIES MARKET IN PRIMARY ANTIBODIES 2018-2026 ($ MILLION)
TABLE 9 CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES
TABLE 10 EUROPE ANTIBODIES MARKET IN SECONDARY ANTIBODIES GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 11 SECONDARY ANTIBODY SELECTION
TABLE 12 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2018-2026 ($ MILLION)
TABLE 13 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY TYPE 2018-2026 ($ MILLION)
TABLE 14 EUROPE EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS 2018-2026 ($ MILLION)
TABLE 15 EUROPE EQUIPMENT MARKET IN TISSUE MICROARRAYS 2018-2026 ($ MILLION)
TABLE 16 EUROPE EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS 2018-2026 ($ MILLION)
TABLE 17 EUROPE EQUIPMENT MARKET IN SLIDE SCANNERS 2018-2026 ($ MILLION)
TABLE 18 EUROPE EQUIPMENT MARKET IN OTHER EQUIPMENT’S 2018-2026 ($ MILLION)
TABLE 19 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)
TABLE 20 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS BY TYPE 2018-2026 ($ MILLION)
TABLE 21 EUROPE REAGENTS MARKET IN HISTOLOGICAL STAINS 2018-2026 ($ MILLION)
TABLE 22 HISTOLOGY STAINS AND ITS CATEGORIES
TABLE 23 EUROPE REAGENTS MARKET IN BLOCKING SERA AND REAGENTS 2018-2026 ($ MILLION)
TABLE 24 EUROPE REAGENTS MARKET IN CHROMOGENIC SUBSTRATES 2018-2026 ($ MILLION)
TABLE 25 EUROPE REAGENTS MARKET IN FIXATION REAGENTS 2018-2026 ($ MILLION)
TABLE 26 COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS
TABLE 27 EUROPE REAGENTS MARKET IN STABILIZERS 2018-2026 ($ MILLION)
TABLE 28 EUROPE REAGENTS MARKET IN ORGANIC SOLVENTS 2018-2026 ($ MILLION)
TABLE 29 EUROPE REAGENTS MARKET IN PROTEOLYTIC ENZYMES 2018-2026 ($ MILLION)
TABLE 30 EUROPE REAGENTS MARKET IN DILUENTS 2018-2026 ($ MILLION)
TABLE 31 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN KITS 2018-2026 ($ MILLION)
TABLE 32 AVAILABLE KIT COMPONENTS FOR IHC OPTIMIZATION
TABLE 33 EUROPE IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2018-2026 ($ MILLION)
TABLE 34 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC 2018-2026 ($ MILLION)
TABLE 35 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC BY TYPES 2018-2026 ($ MILLION)
TABLE 36 EUROPE DIAGNOSTIC MARKET IN CANCER 2018-2026 ($ MILLION)
TABLE 37 EUROPE DIAGNOSTIC MARKET IN INFECTIOUS DISEASES 2018-2026 ($ MILLION)
TABLE 38 EUROPE DIAGNOSTIC MARKET IN CARDIOVASCULAR DISEASE 2018-2026 ($ MILLION)
TABLE 39 EUROPE DIAGNOSTIC MARKET IN AUTOIMMUNE DISEASES 2018-2026 ($ MILLION)
TABLE 40 SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES
TABLE 41 EUROPE DIAGNOSTIC MARKET IN DIABETES MELLITUS 2018-2026 ($ MILLION)
TABLE 42 EUROPE DIAGNOSTIC MARKET IN NEPHROLOGICAL DISEASES 2018-2026 ($ MILLION)
TABLE 43 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2018-2026 ($ MILLION)
TABLE 44 EUROPE IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2018-2026 ($ MILLION)
TABLE 45 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2018-2026 ($ MILLION)
TABLE 46 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2018-2026 ($ MILLION)
TABLE 47 CANCER RESEARCH PROGRAM
TABLE 48 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2018-2026 ($ MILLION)
TABLE 49 IMMUNOHISTOCHEMISTRY USAGE IN FORENSIC PATHOLOGY
TABLE 50 ANTIBODIES MANUFACTURERS IN THE EUROPE IMMUNOHISTOCHEMISTRY MARKET
TABLE 51 EUROPE IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
TABLE 52 NUMBER OF PEOPLE LIVING AND DYING WITH CVD
TABLE 53 NUMBER OF DEATHS CAUSED BY CARDIOVASCULAR DISEASES IN GERMANY 2016
TABLE 54 DISEASES CAUSING PREMATURE DEATH IN GERMANY (2017)
FIGURE LIST
FIGURE 1 EUROPE MARKET FOR IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 2 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2018-2026 ($ MILLION)
FIGURE 3 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2018-2026 ($ MILLION)
FIGURE 4 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)
FIGURE 5 PHASES OF HISTOLOGICAL STAINING
FIGURE 6 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN KITS 2018-2026 ($ MILLION)
FIGURE 7 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC 2018-2026 ($ MILLION)
FIGURE 8 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2018-2026 ($ MILLION)
FIGURE 9 INCIDENCE OF PATIENTS WITH CHRONIC DISEASES IN EUROPE 2005–2030
FIGURE 10 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2018-2026 ($ MILLION)
FIGURE 11 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2018-2026 ($ MILLION)
FIGURE 12 EUROPE IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2018-2026 ($ MILLION)
FIGURE 13 HISTORY OF IMMUNOHISTOCHEMISTRY
FIGURE 14 EUROPE IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 15 THE UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 16 FRANCE IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 17 GERMANY IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 18 SPAIN IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 19 ITALY IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 20 RUSSIA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
FIGURE 21 REST OF EUROPE IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)
- GEOGRAPHICAL ANALYSIS
- EUROPE
- THE UNITED KINGDOM
- FRANCE
- GERMANY
- SPAIN
- ITALY
- RUSSIA
- REST OF EUROPE
- EUROPE
- MARKET SEGMENTATION
- MARKET BY PRODUCTS 2018-2026
- ANTIBODIES
- PRIMARY ANTIBODIES
- SECONDARY ANTIBODIES
- EQUIPMENT
- SLIDE STAINING SYSTEMS
- TISSUE MICROARRAYS
- TISSUE PROCESSING SYSTEMS
- SLIDE SCANNERS
- OTHER EQUIPMENT’S
- REAGENTS
- HISTOLOGICAL STAINS
- BLOCKING SERA AND REAGENTS
- CHROMOGENIC SUBSTRATES
- FIXATION REAGENTS
- STABILIZERS
- ORGANIC SOLVENTS
- PROTEOLYTIC ENZYMES
- DILUENTS
- KITS
- ANTIBODIES
- MARKET BY APPLICATIONS 2018-2026
- DIAGNOSTICS
- CANCER
- INFECTIOUS DISEASES
- CARDIOVASCULAR DISEASE
- AUTOIMMUNE DISEASES
- DIABETES MELLITUS
- NEPHROLOGICAL DISEASES
- DRUG TESTING
- DIAGNOSTICS
- MARKET BY END USERS 2018-2026
- HOSPITALS AND DIAGNOSTIC LABORATORIES
- RESEARCH INSTITUTES
- OTHER END-USERS
- MARKET BY PRODUCTS 2018-2026
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.